18 September 2014 - Deborah Wilkes
Purchasing Insight Pharmaceuticals for US$750 million has pushed Prestige Brands Holdings closer to its stated goal of becoming a billion dollar OTC products player. The deal is the latest in a series of six acquisitions that has taken the US-based company into new categories and countries.
Gain rapid insights into Prestige's strategy with this NEWS EXTRA publication from OTCToolbox, which looks at the company's OTC acquisitions, international growth, latest financial results, and recent product innovations. The company's future plans are also covered.
Around 3,300 words long, this NEWS EXTRA – entitled 'Insight pushes Prestige towards billion dollars' – is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box on this page
This NEWS EXTRA is also available as part of an Annual Subscription to the OTCToolbox website (click here to find out more).
For alternative payment options and delivery methods, or other questions, please send an email to firstname.lastname@example.org.